VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $669,000 | -39.1% | 47,987 | -24.8% | 0.03% | -40.0% |
Q3 2019 | $1,098,000 | +49.4% | 63,787 | +136.4% | 0.06% | +31.0% |
Q2 2019 | $735,000 | +246.7% | 26,987 | +143.4% | 0.04% | +223.1% |
Q1 2019 | $212,000 | -41.3% | 11,087 | -40.0% | 0.01% | -13.3% |
Q2 2018 | $361,000 | -32.0% | 18,476 | -34.7% | 0.02% | -28.6% |
Q1 2018 | $531,000 | – | 28,276 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
Birchview Capital, LP | 30,000 | $516,000 | 0.34% |